STERIS plc (STE) is a good buy for a beginner investor with a long-term strategy and $50,000-$100,000 available for investment. The company shows strong financial growth, stable technical indicators, and a positive options sentiment. Despite no immediate trading signals or significant insider/hedge fund activity, the asset's fundamentals and growth potential make it a solid choice for long-term investment.
The MACD histogram is positive at 0.848, indicating bullish momentum, though it is contracting. RSI is neutral at 52.177, and moving averages are converging, suggesting no strong trend. The stock is trading near its pivot level of 223.125, with key resistance at 226.796 and support at 219.454.

Strong financial performance in Q3 2026 with revenue up 9.17% YoY, net income up 11.16% YoY, and EPS up 12.00% YoY. The company is a leader in infection prevention products, which is a stable and growing industry.
Gross margin decreased by 1.62% YoY, indicating slight pressure on profitability. No recent significant insider or hedge fund activity.
In Q3 2026, revenue increased to $1.496 billion (up 9.17% YoY), net income rose to $192.9 million (up 11.16% YoY), and EPS grew to $1.96 (up 12.00% YoY). However, gross margin dropped to 43.81% (down 1.62% YoY).
No recent updates on analyst ratings or price target changes were provided.